Tomorrow the English company Shire will publish its past quarter's results. Over the current book year the total revenue will be 14,94 billion GBp (consensus estimates). This is quite more than 2016's revenue of 11,4 billion GBp.
The analysts expect for 2018 a net profit of 4,56 billion GBp. The majority of the analysts expects for this year a profit per share of 499 GBp. With this the price/earnings-ratio is 6,41.
Per share the analysts are expecting a dividend of 36 GBp per share. Thus the dividend yield equals 1,13 percent. The average dividend yield of the pharmaceutical companies equals a limited 1 percent.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.